Trial · NCT07295210
Boric Acid Versus 10% Povidone Iodine Solution in Treatment of Otomycosis
NCT07295210, Not applicable, Completed, Mansoura University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Boric Acid Versus 10% Povidone Iodine Solution in Treatment of Otomycosis. Trials, record NCT07295210. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07295210
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Boric Acid Versus 10% Povidone Iodine Solution in Treatment of Otomycosis
- NCT number
- NCT07295210
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 60 participants, actual
- Lead sponsor
- Mansoura University
- Conditions
- Otomycosis
- Interventions
- Boric acid, Povidone iodine 10%
- First posted
- 2025-12-19
- Last updated
- 2025-12-26
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | objective clinical response | Days 7, 14, and 28 after treatment | clinical response is assessed by ear examination by presence or absence of fungal hyphae inside the external auditory canal |
| Primary | Microbiological response | day 28 after treatment | Microbiological response is evaluated by obtaining cultures from the external auditory canal searching for fungal growth |
| Secondary | subjective pain response | days 7, 14, and 28 after treatment | pain is evaluated on a visual analogue scale from 0 to 10 |
| Secondary | subjective itching response | days 7, 14, and 28 after treatment | itching is evaluated on a visual analogue scale from 0 to 10 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07295210
GET https://conductscience.org/api/trials/v1/NCT07295210/registered